What is AWH's earnings growth forecast for 2025-2025?
(NASDAQ: AWH) Aspira Women's Health's forecast annual earnings growth rate of N/A is not forecast to beat the US Diagnostics & Research industry's average forecast earnings growth rate of N/A, and while it is not forecast to beat the US market's average forecast earnings growth rate of N/A.
Aspira Women's Health's earnings in 2025 is -$14,795,000.
In 2025, AWH is forecast to generate -$9,500,335 in earnings, with the lowest earnings forecast at -$9,500,335 and the highest earnings forecast at -$9,500,335.
What is AWH's revenue growth forecast for 2025-2025?
(NASDAQ: AWH) Aspira Women's Health's forecast annual revenue growth rate of N/A is not forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of N/A, and while it is not forecast to beat the US market's average forecast revenue growth rate of N/A.
Aspira Women's Health's revenue in 2025 is $8,963,000.
In 2025, AWH is forecast to generate $205,007,237 in revenue, with the lowest revenue forecast at $205,007,237 and the highest revenue forecast at $205,007,237.
What is AWH's forecast return on assets (ROA) for 2025-2025?
(NASDAQ: AWH) forecast ROA is -199.63%, which is lower than the forecast US Diagnostics & Research industry average of 9.01%.
What is AWH's Earnings Per Share (EPS) forecast for 2025-2025?
(NASDAQ: AWH) Aspira Women's Health's current Earnings Per Share (EPS) is -$1.17. In 2025, AWH's EPS is forecast to hit -$0.57 (min: -$0.57, max: -$0.57).
What is AWH's forecast return on equity (ROE) for 2025-2025?
(NASDAQ: AWH) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.